Llwytho...
Novel Antigens for RSV Vaccines
Respiratory syncytial virus (RSV) remains a leading global cause of infant mortality and adult morbidity. Infection, which recurs throughout life, elicits only short-lived immunity. The development of a safe and efficacious vaccine has, thus far, been elusive. Recent technological advances, however,...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Curr Opin Immunol |
|---|---|
| Prif Awduron: | , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
2015
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4553118/ https://ncbi.nlm.nih.gov/pubmed/26070108 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.coi.2015.04.005 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|